Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Access here alternative investment news about Cumberland Pharmaceuticals Reports 38% Revenue Growth In The First Quarter
Venture Capital

Cumberland Pharmaceuticals Reports 38% Revenue Growth In The First Quarter

by prnewswire.com posted 2months ago 50 views
NASHVILLE, Tenn., May 14, 2019 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on hospital acute care, gastroenterology, and oncology supportive care today announced first quarter 2019 financial results with net revenues of $11.9...